PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in PMV Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- −1 vs. Q4 2022
- Shares held
- 51.5M
- −2.79M (−5.1%) vs. Q4 2022
- Total value
- $245.7M
- −$226.5M (−48.0%) vs. Q4 2022
- New holders
- 15
- 44 more added
- Sold out
- 16
- 36 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 64 | $45.9M |
| Q1 2026 | 69 | $45.8M |
| Q4 2025 | 63 | $46.8M |
| Q3 2025 | 64 | $52.5M |
| Q2 2025 | 54 | $36.8M |
| Q1 2025 | 55 | $40.7M |
| Q4 2024 | 70 | $58.8M |
| Q3 2024 | 74 | $58.2M |
| Q2 2024 | 93 | $65.6M |
| Q1 2024 | 99 | $72.7M |
| Q4 2023 | 98 | $144.0M |
| Q3 2023 | 104 | $333.0M |
| Q2 2023 | 106 | $324.0M |
| Q1 2023 | 113 | $245.7M |
| Q4 2022 | 115 | $474.5M |
| Q3 2022 | 120 | $692.3M |
| Q2 2022 | 105 | $870.9M |
| Q1 2022 | 99 | $1.15B |
| Q4 2021 | 105 | $1.10B |
| Q3 2021 | 92 | $1.31B |
| Q2 2021 | 86 | $1.44B |
| Q1 2021 | 81 | $1.31B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OUP Management Co., LLC | 989,232 | $4.72M | 9.42% | 00.0% | Unchanged |
| Alkeon Capital Management LLC | 1,381,329 | $6.59M | 0.04% | −3,938−0.3% | Reduced |
| Interwest Venture Management Co | 1,614,911 | $7.70M | 37.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,780,104 | $8.49M | 0.01% | +404,005+29.4% | Added |
| Vanguard Group Inc | 1,963,420 | $9.37M | 0.00% | −790,186−28.7% | Reduced |
| Verition Fund Management LLC | 2,147,351 | $10.2M | 0.16% | +1,376,092+178.4% | Added |
| Euclidean Capital LLC | 2,336,909 | $11.1M | 9.78% | 00.0% | Unchanged |
| RTW Investments, LP | 2,999,098 | $14.3M | 0.30% | −1,357,822−31.2% | Reduced |
| Avoro Capital Advisors LLC | 3,060,000 | $14.6M | 0.22% | 00.0% | Unchanged |
| Boxer Capital, LLC | 3,163,795 | $15.1M | 0.74% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 4,002,884 | $19.1M | 0.00% | −93,667−2.3% | Reduced |
| BlackRock Inc. | 4,030,169 | $19.2M | 0.00% | +578,802+16.8% | Added |
| OrbiMed Advisors LLC | 6,563,077 | $31.3M | 0.62% | 00.0% | Unchanged |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −264,772−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −252,308−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −133,122−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −34,147−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −17,600−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −13,884−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −11,191−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −11,180−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −982−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −220−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Monarch Partners Asset Management LLC | – | – | – | – | Not filed |